Dermatitis herpetiformis
- Overview
- Theory
- Diagnosis
- Management
- Follow up
- Resources
Treatment algorithm
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer
all patients
gluten-free diet
Advise all patients with confirmed dermatitis herpetiformis to follow a strict and lifelong gluten-free diet.[2]Görög A, Antiga E, Caproni M, et al. S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2021 Jun;35(6):1251-77. https://onlinelibrary.wiley.com/doi/10.1111/jdv.17183 http://www.ncbi.nlm.nih.gov/pubmed/34004067?tool=bestpractice.com [11]Caproni M, Antiga E, Melani L, et al. Guidelines for the diagnosis and treatment of dermatitis herpetiformis. J Eur Acad Dermatol Venereol. 2009 Jun;23(6):633-8. https://onlinelibrary.wiley.com/doi/10.1111/j.1468-3083.2009.03188.x http://www.ncbi.nlm.nih.gov/pubmed/19470076?tool=bestpractice.com [20]Vale ECSD, Dimatos OC, Porro AM, et al. Consensus on the treatment of autoimmune bullous dermatoses: dermatitis herpetiformis and linear IgA bullous dermatosis - Brazilian Society of Dermatology. An Bras Dermatol. 2019 Apr;94(2 suppl 1):48-55. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544034 http://www.ncbi.nlm.nih.gov/pubmed/31166403?tool=bestpractice.com [21]Al-Toma A, Volta U, Auricchio R, et al. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United European Gastroenterol J. 2019 Jun;7(5):583-613. https://onlinelibrary.wiley.com/doi/10.1177/2050640619844125 http://www.ncbi.nlm.nih.gov/pubmed/31210940?tool=bestpractice.com
Dermatitis herpetiformis is the specific cutaneous manifestation of celiac disease and gluten is the main trigger for both conditions; a lifelong gluten-free diet is necessary to switch off the autoimmune process causing the disease and may help to prevent potential complications, such as lymphoma.[2]Görög A, Antiga E, Caproni M, et al. S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2021 Jun;35(6):1251-77. https://onlinelibrary.wiley.com/doi/10.1111/jdv.17183 http://www.ncbi.nlm.nih.gov/pubmed/34004067?tool=bestpractice.com [43]Lewis HM, Renaula TL, Garioch JJ, et al. Protective effect of gluten-free diet against development of lymphoma in dermatitis herpetiformis. Br J Dermatol. 1996 Sep;135(3):363-7. http://www.ncbi.nlm.nih.gov/pubmed/8949426?tool=bestpractice.com [44]Collin P, Salmi TT, Hervonen K, et al. Dermatitis herpetiformis: a cutaneous manifestation of coeliac disease. Ann Med. 2017 Feb;49(1):23-31. https://www.tandfonline.com/doi/full/10.1080/07853890.2016.1222450 http://www.ncbi.nlm.nih.gov/pubmed/27499257?tool=bestpractice.com
Around 15% to 20% of people with dermatitis herpetiformis show gastrointestinal symptoms resembling those of celiac disease.[2]Görög A, Antiga E, Caproni M, et al. S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2021 Jun;35(6):1251-77. https://onlinelibrary.wiley.com/doi/10.1111/jdv.17183 http://www.ncbi.nlm.nih.gov/pubmed/34004067?tool=bestpractice.com [11]Caproni M, Antiga E, Melani L, et al. Guidelines for the diagnosis and treatment of dermatitis herpetiformis. J Eur Acad Dermatol Venereol. 2009 Jun;23(6):633-8. https://onlinelibrary.wiley.com/doi/10.1111/j.1468-3083.2009.03188.x http://www.ncbi.nlm.nih.gov/pubmed/19470076?tool=bestpractice.com A gluten-free diet alone is usually able to induce the resolution of intestinal signs and symptoms in people with dermatitis herpetiformis (and those with celiac disease) within 3-6 months.[21]Al-Toma A, Volta U, Auricchio R, et al. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United European Gastroenterol J. 2019 Jun;7(5):583-613. https://onlinelibrary.wiley.com/doi/10.1177/2050640619844125 http://www.ncbi.nlm.nih.gov/pubmed/31210940?tool=bestpractice.com [50]Paek SY, Steinberg SM, Katz SI. Remission in dermatitis herpetiformis: a cohort study. Arch Dermatol. 2011 Mar;147(3):301-5. https://jamanetwork.com/journals/jamadermatology/fullarticle/426768 http://www.ncbi.nlm.nih.gov/pubmed/21079050?tool=bestpractice.com
If intestinal symptoms persist following 6 months of gluten-free diet or recur despite adherence to diet, referral for exclusion of other gastrointestinal conditions should be considered.
By contrast, its effects on resolving cutaneous lesions and pruritus is slower, in some instances taking several years; an average of 1-2 years on a gluten-free diet may be required for complete resolution of skin lesions.[21]Al-Toma A, Volta U, Auricchio R, et al. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United European Gastroenterol J. 2019 Jun;7(5):583-613. https://onlinelibrary.wiley.com/doi/10.1177/2050640619844125 http://www.ncbi.nlm.nih.gov/pubmed/31210940?tool=bestpractice.com [51]Hietikko M, Hervonen K, Salmi T, et al. Disappearance of epidermal transglutaminase and IgA deposits from the papillary dermis of patients with dermatitis herpetiformis after a long-term gluten-free diet. Br J Dermatol. 2018 Mar;178(3):e198-e201. http://www.ncbi.nlm.nih.gov/pubmed/28906552?tool=bestpractice.com
Deposited immunoglobulin A (IgA) autoantibodies may be detected in the dermis for up to 10 years after starting a strict gluten-free diet.[2]Görög A, Antiga E, Caproni M, et al. S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2021 Jun;35(6):1251-77. https://onlinelibrary.wiley.com/doi/10.1111/jdv.17183 http://www.ncbi.nlm.nih.gov/pubmed/34004067?tool=bestpractice.com
A study of 237 patients with dermatitis herpetiformis showed that 38% of patients continued to have cutaneous symptoms after 2 years of a gluten-free diet, while 14% had skin symptoms after longer term (mean duration 24 years) gluten-free diet.[52]Pasternack C, Hervonen K, Mansikka E, et al. Persistent skin symptoms after diagnosis and on a long-term gluten-free giet in dermatitis herpetiformis. Acta Derm Venereol. 2021 Sep 22;101(9):adv00555. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425629 http://www.ncbi.nlm.nih.gov/pubmed/34490466?tool=bestpractice.com
Adherence to gluten-free diet is challenging, with one study reporting dietary lapses in approximately 25% of long-term treated patients with dermatitis herpetiformis.[53]Pasternack C, Hervonen K, Mansikka E, et al. Sex-differences in gluten-free dietary adherence and clinical symptoms in patients with long-term treated dermatitis herpetiformis. Acta Derm Venereol. 2022 May 16;102:adv00713. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558333 http://www.ncbi.nlm.nih.gov/pubmed/35393627?tool=bestpractice.com In addition, gluten contamination can be present in food that is intended to be gluten free; one meta-analysis of gluten contamination in naturally gluten-free foods, gluten-free labeled foods, and meals prepared in food services found the overall prevalence of gluten contamination in these foods to be over 15%.[54]Guennouni M, Admou B, El Khoudri N, et al. Gluten contamination in labelled gluten-free, naturally gluten-free and meals in food services in low-, middle- and high-income countries: a systematic review and meta-analysis. Br J Nutr. 2022 May 28;127(10):1528-42. https://www.cambridge.org/core/journals/british-journal-of-nutrition/article/gluten-contamination-in-labelled-glutenfree-naturally-glutenfree-and-meals-in-food-services-in-low-middle-and-highincome-countries-a-systematic-review-and-metaanalysis/0362E5390DCF52A99C6B02A5D45CBA89 http://www.ncbi.nlm.nih.gov/pubmed/34753529?tool=bestpractice.com
For these reasons, other therapeutic strategies are often required in people with dermatitis herpetiformis.
dietary counseling
Treatment recommended for ALL patients in selected patient group
Refer all patients starting a gluten-free diet to a dietitian with training in gluten-free diets.[2]Görög A, Antiga E, Caproni M, et al. S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2021 Jun;35(6):1251-77. https://onlinelibrary.wiley.com/doi/10.1111/jdv.17183 http://www.ncbi.nlm.nih.gov/pubmed/34004067?tool=bestpractice.com [20]Vale ECSD, Dimatos OC, Porro AM, et al. Consensus on the treatment of autoimmune bullous dermatoses: dermatitis herpetiformis and linear IgA bullous dermatosis - Brazilian Society of Dermatology. An Bras Dermatol. 2019 Apr;94(2 suppl 1):48-55. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544034 http://www.ncbi.nlm.nih.gov/pubmed/31166403?tool=bestpractice.com [45]Mehtab W, Singh N, Malhotra A, et al. All that a physician should know about gluten-free diet. Indian J Gastroenterol. 2018 Sep;37(5):392-401. http://www.ncbi.nlm.nih.gov/pubmed/30367395?tool=bestpractice.com Dietary counseling is important because a gluten-free diet has been associated with:
Potential vitamin B deficiency[46]Bledsoe AC, King KS, Larson JJ, et al. Micronutrient deficiencies are common in contemporary celiac disease despite lack of overt malabsorption symptoms. Mayo Clin Proc. 2019 Jul;94(7):1253-60. http://www.ncbi.nlm.nih.gov/pubmed/31248695?tool=bestpractice.com [47]Vici G, Belli L, Biondi M, et al. Gluten free diet and nutrient deficiencies: a review. Clin Nutr. 2016 Dec;35(6):1236-41. http://www.ncbi.nlm.nih.gov/pubmed/27211234?tool=bestpractice.com
Reduced fiber intake
Risk of rebound weight gain.[48]Bascuñán KA, Vespa MC, Araya M. Celiac disease: understanding the gluten-free diet. Eur J Nutr. 2017 Mar;56(2):449-59. http://www.ncbi.nlm.nih.gov/pubmed/27334430?tool=bestpractice.com
Advise all patients on a gluten-free diet to follow a healthy and well balanced diet.[2]Görög A, Antiga E, Caproni M, et al. S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2021 Jun;35(6):1251-77. https://onlinelibrary.wiley.com/doi/10.1111/jdv.17183 http://www.ncbi.nlm.nih.gov/pubmed/34004067?tool=bestpractice.com
Micronutrient and vitamin supplementation may also be a consideration on a case-by-case basis.[2]Görög A, Antiga E, Caproni M, et al. S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2021 Jun;35(6):1251-77. https://onlinelibrary.wiley.com/doi/10.1111/jdv.17183 http://www.ncbi.nlm.nih.gov/pubmed/34004067?tool=bestpractice.com
Some experts recommend avoidance of excessive iodine intake (i.e., via excessive seafood consumption/iodine supplementation), as this may increase risk of relapse in patients with dermatitis herpetiformis.[2]Görög A, Antiga E, Caproni M, et al. S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2021 Jun;35(6):1251-77. https://onlinelibrary.wiley.com/doi/10.1111/jdv.17183 http://www.ncbi.nlm.nih.gov/pubmed/34004067?tool=bestpractice.com
Although an inconsistent manifestation, potassium iodide (ingested or applied topically) may induce a flare-up of symptoms in some patients with dermatitis herpetiformis.[49]Haffenden GP, Blenkinsopp WK, Ring NP, et al. The potassium iodide patch test in the dermatitis herpetiformis in relation to treatment with a gluten-free diet and dapsone. Br J Dermatol. 1980 Sep;103(3):313-7. http://www.ncbi.nlm.nih.gov/pubmed/7426428?tool=bestpractice.com When applied topically, potassium iodide may cause lesions similar to dermatitis herpetiformis (note these may also occur with trauma and other chemical irritants, due to a mechanism known as the Koebner phenomenon).
dapsone
Treatment recommended for SOME patients in selected patient group
Consider starting dapsone in addition to a lifelong gluten-free diet in patients who:[2]Görög A, Antiga E, Caproni M, et al. S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2021 Jun;35(6):1251-77. https://onlinelibrary.wiley.com/doi/10.1111/jdv.17183 http://www.ncbi.nlm.nih.gov/pubmed/34004067?tool=bestpractice.com [11]Caproni M, Antiga E, Melani L, et al. Guidelines for the diagnosis and treatment of dermatitis herpetiformis. J Eur Acad Dermatol Venereol. 2009 Jun;23(6):633-8. https://onlinelibrary.wiley.com/doi/10.1111/j.1468-3083.2009.03188.x http://www.ncbi.nlm.nih.gov/pubmed/19470076?tool=bestpractice.com [20]Vale ECSD, Dimatos OC, Porro AM, et al. Consensus on the treatment of autoimmune bullous dermatoses: dermatitis herpetiformis and linear IgA bullous dermatosis - Brazilian Society of Dermatology. An Bras Dermatol. 2019 Apr;94(2 suppl 1):48-55. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544034 http://www.ncbi.nlm.nih.gov/pubmed/31166403?tool=bestpractice.com [21]Al-Toma A, Volta U, Auricchio R, et al. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United European Gastroenterol J. 2019 Jun;7(5):583-613. https://onlinelibrary.wiley.com/doi/10.1177/2050640619844125 http://www.ncbi.nlm.nih.gov/pubmed/31210940?tool=bestpractice.com
Have intolerable or severe skin involvement at initial presentation, or
Continue to have skin signs and symptoms despite adhering to a strict gluten-free diet.
Dapsone is also an alternative treatment option in patients who cannot adhere to/cannot tolerate a gluten-free diet.[2]Görög A, Antiga E, Caproni M, et al. S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2021 Jun;35(6):1251-77. https://onlinelibrary.wiley.com/doi/10.1111/jdv.17183 http://www.ncbi.nlm.nih.gov/pubmed/34004067?tool=bestpractice.com
Despite the lack of randomized clinical trials on its efficacy, dapsone is considered to be an essential treatment option in these patients as per current guidelines and general expert consensus, with treatment often resulting in the clearance of skin lesions and reduction in pruritus within a few days of treatment.[2]Görög A, Antiga E, Caproni M, et al. S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2021 Jun;35(6):1251-77. https://onlinelibrary.wiley.com/doi/10.1111/jdv.17183 http://www.ncbi.nlm.nih.gov/pubmed/34004067?tool=bestpractice.com [11]Caproni M, Antiga E, Melani L, et al. Guidelines for the diagnosis and treatment of dermatitis herpetiformis. J Eur Acad Dermatol Venereol. 2009 Jun;23(6):633-8. https://onlinelibrary.wiley.com/doi/10.1111/j.1468-3083.2009.03188.x http://www.ncbi.nlm.nih.gov/pubmed/19470076?tool=bestpractice.com [21]Al-Toma A, Volta U, Auricchio R, et al. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United European Gastroenterol J. 2019 Jun;7(5):583-613. https://onlinelibrary.wiley.com/doi/10.1177/2050640619844125 http://www.ncbi.nlm.nih.gov/pubmed/31210940?tool=bestpractice.com [44]Collin P, Salmi TT, Hervonen K, et al. Dermatitis herpetiformis: a cutaneous manifestation of coeliac disease. Ann Med. 2017 Feb;49(1):23-31. https://www.tandfonline.com/doi/full/10.1080/07853890.2016.1222450 http://www.ncbi.nlm.nih.gov/pubmed/27499257?tool=bestpractice.com [55]Bolotin D, Petronic-Rosic V. Dermatitis herpetiformis. Part II. Diagnosis, management, and prognosis. J Am Acad Dermatol. 2011 Jun;64(6):1027-33; quiz 1033-4. http://www.ncbi.nlm.nih.gov/pubmed/21571168?tool=bestpractice.com Dapsone has no effect on gastrointestinal signs and symptoms.
In patients starting dapsone, continue treatment until cutaneous signs and symptoms have completely resolved.[2]Görög A, Antiga E, Caproni M, et al. S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2021 Jun;35(6):1251-77. https://onlinelibrary.wiley.com/doi/10.1111/jdv.17183 http://www.ncbi.nlm.nih.gov/pubmed/34004067?tool=bestpractice.com Monitor the patient closely for adverse effects related to dapsone therapy.
Dapsone may cause hemolytic anemia. Measure serum glucose-6-phosphate-dehydrogenase (G6PD) levels before treatment as severe hemolytic anemia is possible in patients with G6PD deficiency and dapsone should be avoided or used with caution in these patients.
All patients should also have complete blood count (CBC) with differential, liver function tests, renal function tests, urinalysis, and reticulocyte count performed at baseline and then periodically during treatment to monitor for dapsone-related adverse effects.[2]Görög A, Antiga E, Caproni M, et al. S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2021 Jun;35(6):1251-77. https://onlinelibrary.wiley.com/doi/10.1111/jdv.17183 http://www.ncbi.nlm.nih.gov/pubmed/34004067?tool=bestpractice.com [20]Vale ECSD, Dimatos OC, Porro AM, et al. Consensus on the treatment of autoimmune bullous dermatoses: dermatitis herpetiformis and linear IgA bullous dermatosis - Brazilian Society of Dermatology. An Bras Dermatol. 2019 Apr;94(2 suppl 1):48-55. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544034 http://www.ncbi.nlm.nih.gov/pubmed/31166403?tool=bestpractice.com [21]Al-Toma A, Volta U, Auricchio R, et al. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United European Gastroenterol J. 2019 Jun;7(5):583-613. https://onlinelibrary.wiley.com/doi/10.1177/2050640619844125 http://www.ncbi.nlm.nih.gov/pubmed/31210940?tool=bestpractice.com CBC with differential should be checked weekly for the first month, monthly for 6 months, and semi-annually thereafter, when feasible. Discontinue dapsone if there is a significant reduction in leukocytes, platelets, or hemopoiesis.
The majority of dapsone-related adverse effects (including methemoglobinemia, peripheral neuropathy, dizziness, headache, fatigue, nausea, and vomiting) are dose-dependent and for the most part can be rapidly reverted with dose reduction/discontinuation of therapy.
In about 1% to 2% of patients, and usually within the first few weeks of treatment, dapsone can cause a potentially life-threatening idiosyncratic hypersensitivity syndrome resembling drug reaction with eosinophilia and systemic symptoms (DRESS), characterized by fever, skin rash, and organ involvement.[56]Zhu YI, Stiller MJ. Dapsone and sulfones in dermatology: overview and update. J Am Acad Dermatol. 2001 Sep;45(3):420-34. http://www.ncbi.nlm.nih.gov/pubmed/11511841?tool=bestpractice.com Close monitoring of the patient with a particular focus on liver function is advised.
A rare adverse effect of dapsone therapy is idiosyncratic agranulocytosis, which may lead to life-threatening neutropenic sepsis; if affected, the patient typically presents with a fever and evidence of infection 1-3 months following initiation of dapsone.[57]Coleman MD. Dapsone-mediated agranulocytosis: risks, possible mechanisms and prevention. Toxicology. 2001 Apr 12;162(1):53-60. http://www.ncbi.nlm.nih.gov/pubmed/11311458?tool=bestpractice.com Regular monitoring of CBC with differential aims to detect early phases of agranulocytosis before severe effects of neutropenia such as fever and infection occur.
Primary options
dapsone: children: consult specialist for guidance on dose; adults: 25-50 mg orally once daily initially, increase gradually according to response, maximum 100-200 mg/day
topical corticosteroid
Treatment recommended for SOME patients in selected patient group
For patients with localized disease, consider the use of an ultrapotent topical corticosteroid (e.g., clobetasol propionate) alongside dapsone and a gluten-free diet for short-term symptomatic relief of pruritus and to reduce the appearance of new lesions.[8]Bolotin D, Petronic-Rosic V. Dermatitis herpetiformis. Part I. Epidemiology, pathogenesis, and clinical presentation. J Am Acad Dermatol. 2011 Jun;64(6):1017-24; quiz 1025-6. http://www.ncbi.nlm.nih.gov/pubmed/21571167?tool=bestpractice.com [11]Caproni M, Antiga E, Melani L, et al. Guidelines for the diagnosis and treatment of dermatitis herpetiformis. J Eur Acad Dermatol Venereol. 2009 Jun;23(6):633-8. https://onlinelibrary.wiley.com/doi/10.1111/j.1468-3083.2009.03188.x http://www.ncbi.nlm.nih.gov/pubmed/19470076?tool=bestpractice.com [17]Antiga E, Caproni M. The diagnosis and treatment of dermatitis herpetiformis. Clin Cosmet Investig Dermatol. 2015 May 13:8:257-65. https://www.dovepress.com/the-diagnosis-and-treatment-of-dermatitis-herpetiformis-peer-reviewed-fulltext-article-CCID http://www.ncbi.nlm.nih.gov/pubmed/25999753?tool=bestpractice.com [20]Vale ECSD, Dimatos OC, Porro AM, et al. Consensus on the treatment of autoimmune bullous dermatoses: dermatitis herpetiformis and linear IgA bullous dermatosis - Brazilian Society of Dermatology. An Bras Dermatol. 2019 Apr;94(2 suppl 1):48-55. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544034 http://www.ncbi.nlm.nih.gov/pubmed/31166403?tool=bestpractice.com [21]Al-Toma A, Volta U, Auricchio R, et al. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United European Gastroenterol J. 2019 Jun;7(5):583-613. https://onlinelibrary.wiley.com/doi/10.1177/2050640619844125 http://www.ncbi.nlm.nih.gov/pubmed/31210940?tool=bestpractice.com
Topical corticosteroids can be used in children; however, higher potency corticosteroids should be used with caution.
Primary options
clobetasol topical: (0.05%) children ≥12 years of age and adults: apply sparingly to the affected area(s) twice daily for up to 2 weeks, maximum 50 g/week
sulfasalazine
Sulfasalazine is a second-line option if dapsone is contraindicated or not effective in controlling the disease despite adherence to a gluten-free diet.[2]Görög A, Antiga E, Caproni M, et al. S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2021 Jun;35(6):1251-77. https://onlinelibrary.wiley.com/doi/10.1111/jdv.17183 http://www.ncbi.nlm.nih.gov/pubmed/34004067?tool=bestpractice.com [11]Caproni M, Antiga E, Melani L, et al. Guidelines for the diagnosis and treatment of dermatitis herpetiformis. J Eur Acad Dermatol Venereol. 2009 Jun;23(6):633-8. https://onlinelibrary.wiley.com/doi/10.1111/j.1468-3083.2009.03188.x http://www.ncbi.nlm.nih.gov/pubmed/19470076?tool=bestpractice.com [20]Vale ECSD, Dimatos OC, Porro AM, et al. Consensus on the treatment of autoimmune bullous dermatoses: dermatitis herpetiformis and linear IgA bullous dermatosis - Brazilian Society of Dermatology. An Bras Dermatol. 2019 Apr;94(2 suppl 1):48-55. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544034 http://www.ncbi.nlm.nih.gov/pubmed/31166403?tool=bestpractice.com [21]Al-Toma A, Volta U, Auricchio R, et al. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United European Gastroenterol J. 2019 Jun;7(5):583-613. https://onlinelibrary.wiley.com/doi/10.1177/2050640619844125 http://www.ncbi.nlm.nih.gov/pubmed/31210940?tool=bestpractice.com
Sulfasalazine is considerably less effective than dapsone and only anecdotal case reports are available to support its use in this setting.[2]Görög A, Antiga E, Caproni M, et al. S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2021 Jun;35(6):1251-77. https://onlinelibrary.wiley.com/doi/10.1111/jdv.17183 http://www.ncbi.nlm.nih.gov/pubmed/34004067?tool=bestpractice.com [11]Caproni M, Antiga E, Melani L, et al. Guidelines for the diagnosis and treatment of dermatitis herpetiformis. J Eur Acad Dermatol Venereol. 2009 Jun;23(6):633-8. https://onlinelibrary.wiley.com/doi/10.1111/j.1468-3083.2009.03188.x http://www.ncbi.nlm.nih.gov/pubmed/19470076?tool=bestpractice.com [20]Vale ECSD, Dimatos OC, Porro AM, et al. Consensus on the treatment of autoimmune bullous dermatoses: dermatitis herpetiformis and linear IgA bullous dermatosis - Brazilian Society of Dermatology. An Bras Dermatol. 2019 Apr;94(2 suppl 1):48-55. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544034 http://www.ncbi.nlm.nih.gov/pubmed/31166403?tool=bestpractice.com [21]Al-Toma A, Volta U, Auricchio R, et al. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United European Gastroenterol J. 2019 Jun;7(5):583-613. https://onlinelibrary.wiley.com/doi/10.1177/2050640619844125 http://www.ncbi.nlm.nih.gov/pubmed/31210940?tool=bestpractice.com [58]Willsteed E, Lee M, Wong LC, et al. Sulfasalazine and dermatitis herpetiformis. Australas J Dermatol. 2005 May;46(2):101-3. http://www.ncbi.nlm.nih.gov/pubmed/15842404?tool=bestpractice.com [59]Shah SA, Ormerod AD. Dermatitis herpetiformis effectively treated with heparin, tetracycline and nicotinamide. Clin Exp Dermatol. 2000 May;25(3):204-5. http://www.ncbi.nlm.nih.gov/pubmed/10844495?tool=bestpractice.com [60]Zemtsov A, Neldner KH. Successful treatment of dermatitis herpetiformis with tetracycline and nicotinamide in a patient unable to tolerate dapsone. J Am Acad Dermatol. 1993 Mar;28(3):505-6. http://www.ncbi.nlm.nih.gov/pubmed/8445075?tool=bestpractice.com [61]Wang Y, Yang B, Zhou G, et al. Two cases of dermatitis herpetiformis successfully treated with tetracycline and niacinamide. Acta Dermatovenerol Croat. 2018 Oct;26(3):273-5. http://www.ncbi.nlm.nih.gov/pubmed/30390734?tool=bestpractice.com
Primary options
sulfasalazine: children ≥6 years of age: 40-60 mg/kg/day orally given in divided doses every 4-8 hours initially, followed by 30 mg/kg/day given in divided doses every 6 hours, maximum 4 g/day; adults: 1 g orally every 6-8 hours initially, followed by 500 mg every 6-12 hours, maximum 4 g/day
gluten-free diet
Treatment recommended for ALL patients in selected patient group
Advise all patients with confirmed dermatitis herpetiformis to follow a strict and lifelong gluten-free diet.[2]Görög A, Antiga E, Caproni M, et al. S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2021 Jun;35(6):1251-77. https://onlinelibrary.wiley.com/doi/10.1111/jdv.17183 http://www.ncbi.nlm.nih.gov/pubmed/34004067?tool=bestpractice.com [11]Caproni M, Antiga E, Melani L, et al. Guidelines for the diagnosis and treatment of dermatitis herpetiformis. J Eur Acad Dermatol Venereol. 2009 Jun;23(6):633-8. https://onlinelibrary.wiley.com/doi/10.1111/j.1468-3083.2009.03188.x http://www.ncbi.nlm.nih.gov/pubmed/19470076?tool=bestpractice.com [20]Vale ECSD, Dimatos OC, Porro AM, et al. Consensus on the treatment of autoimmune bullous dermatoses: dermatitis herpetiformis and linear IgA bullous dermatosis - Brazilian Society of Dermatology. An Bras Dermatol. 2019 Apr;94(2 suppl 1):48-55. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544034 http://www.ncbi.nlm.nih.gov/pubmed/31166403?tool=bestpractice.com [21]Al-Toma A, Volta U, Auricchio R, et al. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United European Gastroenterol J. 2019 Jun;7(5):583-613. https://onlinelibrary.wiley.com/doi/10.1177/2050640619844125 http://www.ncbi.nlm.nih.gov/pubmed/31210940?tool=bestpractice.com
Dermatitis herpetiformis is the specific cutaneous manifestation of celiac disease and gluten is the main trigger for both conditions; a lifelong gluten-free diet is necessary to switch off the autoimmune process causing the disease and may help to prevent potential complications, such as other autoimmune diseases and lymphoma.[2]Görög A, Antiga E, Caproni M, et al. S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2021 Jun;35(6):1251-77. https://onlinelibrary.wiley.com/doi/10.1111/jdv.17183 http://www.ncbi.nlm.nih.gov/pubmed/34004067?tool=bestpractice.com [43]Lewis HM, Renaula TL, Garioch JJ, et al. Protective effect of gluten-free diet against development of lymphoma in dermatitis herpetiformis. Br J Dermatol. 1996 Sep;135(3):363-7. http://www.ncbi.nlm.nih.gov/pubmed/8949426?tool=bestpractice.com [44]Collin P, Salmi TT, Hervonen K, et al. Dermatitis herpetiformis: a cutaneous manifestation of coeliac disease. Ann Med. 2017 Feb;49(1):23-31. https://www.tandfonline.com/doi/full/10.1080/07853890.2016.1222450 http://www.ncbi.nlm.nih.gov/pubmed/27499257?tool=bestpractice.com
Around 15% to 20% of people with dermatitis herpetiformis show gastrointestinal symptoms resembling those of celiac disease.[2]Görög A, Antiga E, Caproni M, et al. S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2021 Jun;35(6):1251-77. https://onlinelibrary.wiley.com/doi/10.1111/jdv.17183 http://www.ncbi.nlm.nih.gov/pubmed/34004067?tool=bestpractice.com [11]Caproni M, Antiga E, Melani L, et al. Guidelines for the diagnosis and treatment of dermatitis herpetiformis. J Eur Acad Dermatol Venereol. 2009 Jun;23(6):633-8. https://onlinelibrary.wiley.com/doi/10.1111/j.1468-3083.2009.03188.x http://www.ncbi.nlm.nih.gov/pubmed/19470076?tool=bestpractice.com A gluten-free diet alone is usually able to induce the resolution of intestinal signs and symptoms in people with dermatitis herpetiformis (and those with celiac disease) within 3-6 months.[21]Al-Toma A, Volta U, Auricchio R, et al. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United European Gastroenterol J. 2019 Jun;7(5):583-613. https://onlinelibrary.wiley.com/doi/10.1177/2050640619844125 http://www.ncbi.nlm.nih.gov/pubmed/31210940?tool=bestpractice.com [50]Paek SY, Steinberg SM, Katz SI. Remission in dermatitis herpetiformis: a cohort study. Arch Dermatol. 2011 Mar;147(3):301-5. https://jamanetwork.com/journals/jamadermatology/fullarticle/426768 http://www.ncbi.nlm.nih.gov/pubmed/21079050?tool=bestpractice.com
If intestinal symptoms persist following 6 months of gluten-free diet or recur despite adherence to diet, referral for exclusion of other gastrointestinal conditions should be considered.
By contrast, its effects on resolving cutaneous lesions and pruritus is slower, in some instances taking several years; an average of 1-2 years on a gluten-free diet may be required for complete resolution of skin lesions.[21]Al-Toma A, Volta U, Auricchio R, et al. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United European Gastroenterol J. 2019 Jun;7(5):583-613. https://onlinelibrary.wiley.com/doi/10.1177/2050640619844125 http://www.ncbi.nlm.nih.gov/pubmed/31210940?tool=bestpractice.com [51]Hietikko M, Hervonen K, Salmi T, et al. Disappearance of epidermal transglutaminase and IgA deposits from the papillary dermis of patients with dermatitis herpetiformis after a long-term gluten-free diet. Br J Dermatol. 2018 Mar;178(3):e198-e201. http://www.ncbi.nlm.nih.gov/pubmed/28906552?tool=bestpractice.com
Deposited immunoglobulin A (IgA) autoantibodies may be detected in the dermis for up to 10 years after starting a strict gluten-free diet.[2]Görög A, Antiga E, Caproni M, et al. S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2021 Jun;35(6):1251-77. https://onlinelibrary.wiley.com/doi/10.1111/jdv.17183 http://www.ncbi.nlm.nih.gov/pubmed/34004067?tool=bestpractice.com
A study of 237 patients with dermatitis herpetiformis showed that 38% of patients continued to have cutaneous symptoms after 2 years of a gluten-free diet, while 14% had skin symptoms after longer term (mean duration 24 years) gluten-free diet.[52]Pasternack C, Hervonen K, Mansikka E, et al. Persistent skin symptoms after diagnosis and on a long-term gluten-free giet in dermatitis herpetiformis. Acta Derm Venereol. 2021 Sep 22;101(9):adv00555. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425629 http://www.ncbi.nlm.nih.gov/pubmed/34490466?tool=bestpractice.com
Adherence to gluten-free diet is challenging, with one study reporting dietary lapses in approximately 25% of long-term treated patients with dermatitis herpetiformis.[53]Pasternack C, Hervonen K, Mansikka E, et al. Sex-differences in gluten-free dietary adherence and clinical symptoms in patients with long-term treated dermatitis herpetiformis. Acta Derm Venereol. 2022 May 16;102:adv00713. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558333 http://www.ncbi.nlm.nih.gov/pubmed/35393627?tool=bestpractice.com In addition, gluten contamination can be present in food that is intended to be gluten free; one meta-analysis of gluten contamination in naturally gluten-free foods, gluten-free labeled foods, and meals prepared in food services found the overall prevalence of gluten contamination in these foods to be over 15%.[54]Guennouni M, Admou B, El Khoudri N, et al. Gluten contamination in labelled gluten-free, naturally gluten-free and meals in food services in low-, middle- and high-income countries: a systematic review and meta-analysis. Br J Nutr. 2022 May 28;127(10):1528-42. https://www.cambridge.org/core/journals/british-journal-of-nutrition/article/gluten-contamination-in-labelled-glutenfree-naturally-glutenfree-and-meals-in-food-services-in-low-middle-and-highincome-countries-a-systematic-review-and-metaanalysis/0362E5390DCF52A99C6B02A5D45CBA89 http://www.ncbi.nlm.nih.gov/pubmed/34753529?tool=bestpractice.com
For these reasons, other therapeutic strategies are often required in people with dermatitis herpetiformis.
dietary counseling
Treatment recommended for ALL patients in selected patient group
Refer all patients starting a gluten-free diet to a dietitian with training in gluten-free diets.[2]Görög A, Antiga E, Caproni M, et al. S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2021 Jun;35(6):1251-77. https://onlinelibrary.wiley.com/doi/10.1111/jdv.17183 http://www.ncbi.nlm.nih.gov/pubmed/34004067?tool=bestpractice.com [20]Vale ECSD, Dimatos OC, Porro AM, et al. Consensus on the treatment of autoimmune bullous dermatoses: dermatitis herpetiformis and linear IgA bullous dermatosis - Brazilian Society of Dermatology. An Bras Dermatol. 2019 Apr;94(2 suppl 1):48-55. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544034 http://www.ncbi.nlm.nih.gov/pubmed/31166403?tool=bestpractice.com [45]Mehtab W, Singh N, Malhotra A, et al. All that a physician should know about gluten-free diet. Indian J Gastroenterol. 2018 Sep;37(5):392-401. http://www.ncbi.nlm.nih.gov/pubmed/30367395?tool=bestpractice.com Dietary counseling is important because a gluten-free diet has been associated with:
Potential vitamin B deficiency[46]Bledsoe AC, King KS, Larson JJ, et al. Micronutrient deficiencies are common in contemporary celiac disease despite lack of overt malabsorption symptoms. Mayo Clin Proc. 2019 Jul;94(7):1253-60. http://www.ncbi.nlm.nih.gov/pubmed/31248695?tool=bestpractice.com [47]Vici G, Belli L, Biondi M, et al. Gluten free diet and nutrient deficiencies: a review. Clin Nutr. 2016 Dec;35(6):1236-41. http://www.ncbi.nlm.nih.gov/pubmed/27211234?tool=bestpractice.com
Reduced fiber intake
Risk of rebound weight gain.[48]Bascuñán KA, Vespa MC, Araya M. Celiac disease: understanding the gluten-free diet. Eur J Nutr. 2017 Mar;56(2):449-59. http://www.ncbi.nlm.nih.gov/pubmed/27334430?tool=bestpractice.com
Advise all patients on a gluten-free diet to follow a healthy and well balanced diet.[2]Görög A, Antiga E, Caproni M, et al. S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2021 Jun;35(6):1251-77. https://onlinelibrary.wiley.com/doi/10.1111/jdv.17183 http://www.ncbi.nlm.nih.gov/pubmed/34004067?tool=bestpractice.com
Micronutrient and vitamin supplementation may also be a consideration on a case-by-case basis.[2]Görög A, Antiga E, Caproni M, et al. S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2021 Jun;35(6):1251-77. https://onlinelibrary.wiley.com/doi/10.1111/jdv.17183 http://www.ncbi.nlm.nih.gov/pubmed/34004067?tool=bestpractice.com
Some experts recommend avoidance of excessive iodine intake (i.e., via excessive seafood consumption/iodine supplementation), as this may increase risk of relapse in patients with dermatitis herpetiformis.[2]Görög A, Antiga E, Caproni M, et al. S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2021 Jun;35(6):1251-77. https://onlinelibrary.wiley.com/doi/10.1111/jdv.17183 http://www.ncbi.nlm.nih.gov/pubmed/34004067?tool=bestpractice.com
Although an inconsistent manifestation, potassium iodide (ingested or applied topically) may induce a flare-up of symptoms in some patients with dermatitis herpetiformis.[49]Haffenden GP, Blenkinsopp WK, Ring NP, et al. The potassium iodide patch test in the dermatitis herpetiformis in relation to treatment with a gluten-free diet and dapsone. Br J Dermatol. 1980 Sep;103(3):313-7. http://www.ncbi.nlm.nih.gov/pubmed/7426428?tool=bestpractice.com When applied topically, potassium iodide may cause lesions similar to dermatitis herpetiformis (note these may also occur with trauma and other chemical irritants, due to a mechanism known as the Koebner phenomenon).
topical corticosteroid
Treatment recommended for SOME patients in selected patient group
For patients with localized disease, consider the use of an ultrapotent topical corticosteroid (e.g., clobetasol propionate) alongside sulfasalazine and a gluten-free diet for short-term symptomatic relief of pruritus and to reduce the appearance of new lesions.[8]Bolotin D, Petronic-Rosic V. Dermatitis herpetiformis. Part I. Epidemiology, pathogenesis, and clinical presentation. J Am Acad Dermatol. 2011 Jun;64(6):1017-24; quiz 1025-6. http://www.ncbi.nlm.nih.gov/pubmed/21571167?tool=bestpractice.com [11]Caproni M, Antiga E, Melani L, et al. Guidelines for the diagnosis and treatment of dermatitis herpetiformis. J Eur Acad Dermatol Venereol. 2009 Jun;23(6):633-8. https://onlinelibrary.wiley.com/doi/10.1111/j.1468-3083.2009.03188.x http://www.ncbi.nlm.nih.gov/pubmed/19470076?tool=bestpractice.com [17]Antiga E, Caproni M. The diagnosis and treatment of dermatitis herpetiformis. Clin Cosmet Investig Dermatol. 2015 May 13:8:257-65. https://www.dovepress.com/the-diagnosis-and-treatment-of-dermatitis-herpetiformis-peer-reviewed-fulltext-article-CCID http://www.ncbi.nlm.nih.gov/pubmed/25999753?tool=bestpractice.com [20]Vale ECSD, Dimatos OC, Porro AM, et al. Consensus on the treatment of autoimmune bullous dermatoses: dermatitis herpetiformis and linear IgA bullous dermatosis - Brazilian Society of Dermatology. An Bras Dermatol. 2019 Apr;94(2 suppl 1):48-55. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544034 http://www.ncbi.nlm.nih.gov/pubmed/31166403?tool=bestpractice.com [21]Al-Toma A, Volta U, Auricchio R, et al. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United European Gastroenterol J. 2019 Jun;7(5):583-613. https://onlinelibrary.wiley.com/doi/10.1177/2050640619844125 http://www.ncbi.nlm.nih.gov/pubmed/31210940?tool=bestpractice.com
Topical corticosteroids can be used in children; however, higher potency corticosteroids should be used with caution.
Primary options
clobetasol topical: (0.05%) children ≥12 years of age and adults: apply sparingly to the affected area(s) twice daily for up to 2 weeks, maximum 50 g/week
Choose a patient group to see our recommendations
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer
Use of this content is subject to our disclaimer